How many clinical trials are studying SHR-A1921?

4 recruiting trials in our tracked data involve SHR-A1921.

What conditions is SHR-A1921 being studied for?

In our tracked recruiting trials, SHR-A1921 is being studied in trials for Breast Cancer, Advanced Breast Cancer, HER2-negative Breast Cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 4

Condition	Trials
Breast Cancer · SHR-A1921 for Breast Cancer	4
Advanced Breast Cancer · SHR-A1921 for Advanced Breast Cancer	3
HER2-negative Breast Cancer · SHR-A1921 for HER2-negative Breast Cancer	3
Breast Neoplasm	2
Hormone Receptor Positive Tumor	2
Triple Negative Breast Cancer (TNBC)	2
Breast Tumors	1
Early-stage Breast Cancer	1
HER2-positive Breast Cancer	1
Hormone Receptor Negative Tumor	1
Locally Advanced Breast Cancer	1
Metastatic Breast Cancer	1

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT06649331 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
NCT05594095 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer
NCT06433609 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location